Eric Lefkofsky announced that Tempus had entered into a partnership with the University of Chicago last month. Tempus will give doctors at the institution data so that they can treat cancer patients in a better way. The company will give breast cancer specialists the tools to perform molecular sequencing and analysis. This will help them to come up with a personalized treatment scheme for each patient. The company will perform analyses on the data from various patients to see if they can tell how the patients will respond to the treatment prescribed.
Dr. OlufunmilayoOlopade is a professor of Medicine at the University. He noted that there is minimal data on breast cancer patients even though it is one of the most prevalent forms of cancer. This forces physician to make uninformed decisions because they do not have specific genetic information.Olopade went on to state that he was excited about the partnership with Tempus. He was glad that the university could help them build the largest breast cancer molecular data set.
The University of Chicago is one of many organizations that has struck a partnership with Tempus. They have entered into partnerships with the University of Michigan, Penn Medicine, and the Robert Lurie Comprehensive Cancer Center of Northwestern University. Eric Lefkofsky is the CEO and co-founder of Tempus. He is the chairman and co-founder of Groupon, the highly successful e-commerce marketplace. He also started Mediaocean. This is a media procurement technology provider and Uptake Technologies. It is a predictive analytics company.Lefkofsky has been heavily involved in charity. This led him to establish the Lefkofsky Family Foundation in 2006. He started the charitable foundation with his wife. Its primary goal is to enhance communities worldwide. Lefkofsky is a graduate of the University of Michigan. He received a J.D from the same university. Lefkofsky also gives lectures and is an adjunct professor at the University of Chicago.